The Influence of BRCA1/BRCA2 Mutations on Toxicity Related to Chemotherapy and Radiotherapy in Early Breast Cancer Patients

Publisher： Karger

E-ISSN： 1423-0232|85|5|278-282

ISSN： 0030-2414

Source： Oncology, Vol.85, Iss.5, 2013-11, pp. : 278-282

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Management of early-onset breast cancer and BRCA1 or BRCA2 status

By Haffty B.G.  

The Lancet, Vol. 360, Iss. 333, 2002-08 ,pp. : 640-641

Elsevier

Access to resources Recommend Favorite

Management of early-onset breast cancer and BRCA1 or BRCA2 status

By Vaidya J.S.   Baum M.  

The Lancet, Vol. 360, Iss. 333, 2002-08 ,pp. : 640-640

Elsevier

Access to resources Recommend Favorite

Characteristics of individuals with breast cancer rearrangements in BRCA1 and BRCA2

By  

CANCER, Vol. 120, Iss. 10, 2014-05 ,pp. : 1557-1564

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical implications of the breast cancer susceptibility genes BRCA1 and BRCA2

By Narod Steven A  

Women's Health, Vol. 1, Iss. 1, 2005-07 ,pp. : 27-34

Future Medicine

Access to resources Recommend Favorite

Age at Onset of Bilateral Breast Cancer, the Presence of Hereditary BRCA1, BRCA2, CHEK2 Gene Mutations and Positive Family History of Cancer

By  

Oncology Research and Treatment, Vol. 32, Iss. 4, 2009-03 ,pp. : 182-188

Karger

Access to resources Recommend Favorite